More research is still required, but Field Medical's FieldForce Ablation System may represent a significant step forward in the treatment of scar-related ventricular tachycardia.

Imagers can now identify vulnerable plaques that were once very challenging to find. The next steps include improving the screening process and determining which lesions need to be treated right away.

The new software provides automated measurements that save time and improve the care of aortic aneurysm patients. 

Prescribing these drugs to TAVR patients could improve certain clinical outcomes, according to a new study of nearly 27,000 adults. 

Atrial fibrillation (AFib), the most common heart rhythm disorder, continues to rise globally - it is predicted to affect more than 12 million people in the US by 2030 and almost 18 million people in Europe by 2060. With a growing aging population and an increased prevalence of heart disease, the demand for effective treatments for AFib is higher than ever before. 

Cardiologists, cardiac surgeons and cardiology APPs all earned more in 2024 than 2023, according to a new survey. Compensation in private practices continues to be much lower than it is integrated practices. 

"PET has changed the practice of nuclear medicine in general and I think it is going to revitalize the practice of cardiology,"  Marcelo Di Carli, MD, told Cardiovascular Business. He noted that more practices seem interested in implementing PET than ever before.

When patients require PCI and TAVR, performing them at the same time is associated with both short- and long-term benefits. 

Stereotaxis and CardioFocus are collaborating on a new robotic pulsed field ablation system. After completing some initial research, the companies are now working toward the launch of a clinical trial. 

The annual list is based on resources, services provided, outcomes data and survey responses from thousands of physicians. Did your facility make the cut?

The co-chairs of the American Society of Echocardiography's 2025 meeting wanted to "highlight the unique value of being in person." They looked back at the three-day event with Cardiovascular Business.

Michael Minogue spent nearly two decades as the chairman, president and CEO of Abiomed, and now he is running to be the next governor of Massachusetts. 

The prescription information comes from 626 pharmacies in 15 states. CVS said it could gain access to 9 million new customers. 

The Guilford, Connecticut-based manufacturer saw quarterly revenues climb 27% compared to the second quarter of 2025, with scanners priced at $360,000 (up 36%).